Nama's AI scorecard currently rates HealthEquity Buy (8.2 out of 10), a call computed from its profitability, cash generation, growth, valuation and balance sheet. It is a research reading, not investment advice.

What is HQY's P/E ratio?

HealthEquity trades at a trailing price-to-earnings ratio of 23.3.

When does HQY report earnings?

HealthEquity's next scheduled report is on Dec 2, 2026. Analysts expect EPS of $1.15.

What is the HQY price target?

The median analyst price target from 15 analysts is $123.00, with a range of $108.00 – $142.00.

Is HQY Shariah compliant?

Nama's AAOIFI-style screen reads HealthEquity as Shariah Compliant. Passes our debt, cash and income screen; not a scholar's ruling.

Nama Insights

HealthEquity (HQY)

Healthcare · Health Information Services · NASDAQ

HealthEquity (HQY) is a Healthcare company in the Health Information Services industry. It has a market capitalization of $8.57B, a trailing price-to-earnings ratio of 23.3 and a free-cash-flow yield of 4.5%. Over the most recent reported fiscal year, revenue grew 9.5%. Nama's AI scorecard rates it Buy, 8.2 out of 10. On 12-month momentum it ranks in the lagging band of its market.

AI scorecard

Buy · 8.2/10

Clearly positive, short of the top band. As of Nov 7, 2026.

Momentum

Lagging · -0.9% over 12 months ex. last

Second-worst fifth of its market on the past year's move.

Shariah screen

Shariah Compliant

Passes our debt, cash and income screen; not a scholar's ruling.

Off its high

-11.2%

How far the last close sits under the highest price of the past five years.

Market cap	$8.57B
Trailing P/E	23.3
Price / book	4.3
Price / sales	6.3
FCF yield	4.5%
Dividend yield	—
Gross margin	71.2%
Operating margin	26.1%
Net margin	17.4%
Revenue growth (YoY)	+9.5%
Revenue growth (3-yr annual)	+15.1%
EPS growth (YoY)	+28.1%
FCF/share growth (YoY)	—
Beta	0.2
Exchange	NASDAQ
Sector	Healthcare
Industry	Health Information Services

HQY earnings

Next report: Dec 2, 2026 (Q3 2027, EPS estimate $1.15). Beat the EPS estimate in 4 of 4 recent quarters.

Quarter	Reported	EPS	Estimate	Surprise	Revenue
Q2 2027	Aug 27, 2026	$1.24	$1.19	+4.2%	$350.73M
Q1 2027	May 28, 2026	$1.24	$1.12	+10.7%	$354.64M
Q4 2026	Mar 17, 2026	$0.95	$0.90	+5.6%	$334.59M
Q3 2026	Dec 3, 2025	$1.01	$0.91	+11.0%	$322.16M

HQY analyst price target

Median target $123.00 from 15 analysts, ranging $108.00 – $142.00.

Health Information Services peers

Ticker	Company	Market cap	P/E
VEEV	Veeva Systems	$49.18B	35.0
TEM	Tempus AI	$13.87B	—
BTSG	BrightSpring Health Services	$13.36B	39.3
HNGE	Hinge Health	$9.34B	51.7
TXG	10x Genomics	$7.72B	296.4
DOCS	Doximity	$5.79B	23.7
WAY	Waystar	$5.45B	17.2
HTFL	Heartflow	$4.56B	—

Explore live HQY data on Nama Insights →

Recent Congressional trades

HealthEquity trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →

Member	Chamber	Trade	Amount	Disclosed
Gilbert Cisneros	House	Buy	$1,001 - $15,000	Sep 4, 2026
Gilbert Cisneros	House	Buy	$1,001 - $15,000	Jul 2, 2026
Gilbert Cisneros	House	Buy	$1,001 - $15,000	Jun 8, 2026
Lisa McClain	House	Sell	$1,001 - $15,000	Aug 13, 2025
Lisa McClain	House	Buy	$1,001 - $15,000	Aug 13, 2025
Gilbert Cisneros	House	Sell	$1,001 - $15,000	Jul 10, 2025
Rob Bresnahan	House	Sell	$1,001 - $15,000	Feb 13, 2025
Josh Gottheimer	House	Sell	$1,001 - $15,000	Dec 5, 2024
Josh Gottheimer	House	Sell	$1,001 - $15,000	Jul 9, 2024
Blake Moore	House	Sell	$1,001 - $15,000	Jan 24, 2024

HQY FAQ

Is HQY a buy?: Nama's AI scorecard currently rates HealthEquity Buy (8.2 out of 10), a call computed from its profitability, cash generation, growth, valuation and balance sheet. It is a research reading, not investment advice.
What is HQY's P/E ratio?: HealthEquity trades at a trailing price-to-earnings ratio of 23.3.
When does HQY report earnings?: HealthEquity's next scheduled report is on Dec 2, 2026. Analysts expect EPS of $1.15.
What is the HQY price target?: The median analyst price target from 15 analysts is $123.00, with a range of $108.00 – $142.00.
Is HQY Shariah compliant?: Nama's AAOIFI-style screen reads HealthEquity as Shariah Compliant. Passes our debt, cash and income screen; not a scholar's ruling.